MTRC has launched platform for online education and seminars on market access

06

May 2019

Market access is a complex discipline that includes topics of reimbursement, funding, health technology assessment, clinical epidemiology, and stakeholder engagement.

At the moment, there is no good introductory training in market access for medical devices in Europe. Market access professionals develop an understanding of the disciple through work experience and conferences.

MTRC is bridging the gap with its novel product - “Med Tech Market Access Academy” (www.a-marketaccess.com). 

“Med Tech Market Access Academy” is a unique repository of online courses and seminars on European market access for medical devices and in-vitro diagnostic tests.

Seminars are delivered as pre-recorded webinars and cover a general introduction into market access, and country-specific overviews. We are launching the platform with 6 seminars (general introduction into market access, and reimbursement overviews in EU5) and expect to add 4-6 seminars each month.

Introductory course on market access (3 hours) covers the topics of reimbursement, payment mechanisms, DRG system, innovation payment schemes, funding and willingness to pay, role of clinical and economic evidence, health technology assessment, stakeholder engagement and reimbursement pathways. 

Reimbursement overviews of individual European countries include information about key stakeholders, money flow, payment mechanisms, DRG system, innovation funding landscape, funding frameworks, the role of health technology assessment. 

Plans for the release of seminars in May-July 2019:

  • May 2019: country overviews for Finland, Denmark, Norway, Sweden
  • June 2019: EU introduction into market access for IVD tests; country overviews for Austria, Belgium, Czech Republic, Russia, and Switzerland
  • July 2019: country overviews for Hungary, the Netherlands, Romania; overview of innovative payment schemes in Europe

You can access online school at the website https://www.a-marketaccess.com/

Related news

17

May 2019

The report summarizes HTA landscape, role of HTA in reimbursement processes in individual countries, provides list of HTAs per country, HTA body and program, per type of technology. In total, 12 countries, 51 organizations and more than 850 reports are included. Sample pages are available for download.

Read more

06

May 2019

We are happy to announce the start of the first Youtube channel dedicated to market access for medical devices, in-vitro diagnostic tests, and e-health solutions, “Market Access Insider”. In the first season of the program, we will weekly release videos of interviews with decision-makers, researchers, consultants, physicians and patient representatives on the topics of the payment system, health insurance, reimbursement pathways, health technology assessment and others in European countries. The first season will include interviews with experts from the Czech Republic, France, Germany, Italy, the Netherlands, and Spain.

Read more

16

Nov 2018

MTRC is offering an opportunity to access 2019 market access retainer scheme using the discounted price during November-December 2018. The benefit to our clients of entering into this scheme is the forward planning of market access-related project activities and more effective budget management.

Read more

08

Oct 2018

MTRC expands the coverage of EU countries with its core service of reimbursement analysis (procedure coding, payment model, reimbursement tariffs). Work is done by MTRC personnel, supported by local reimbursement experts. Contact us, if you want to learn more.

Read more

04

Oct 2018

The article "Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model", published in Plos One presented the cost effectiveness of tissue engineered bovine tissue pericardium scaffold (CardioCel) for the repair of congenital heart defects in comparison with surgery using xenogeneic, autologous, and synthetic patches over a 40-year time horizon from the perspective of the UK National Health Service.

Read more

09

Sep 2018

MTRC performs the analysis using administrative databases. Reporting of procedure volume is done according to the established procedural classifications (e.g., OPCS in England, OPS in Germany). Data are available for Austria, Belgium, England, France, Germany, the Netherlands, Sweden, and Switzerland. In other countries, it might be possible to obtain data from patient registries or clinical societies.

Read more

10

Aug 2018

An article “An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany” was published in the BMC Cardiovascular Disorders. The study concluded that Baroreflex activation therapy (BAT) using the Barostim neo™ device (CVRx Inc., Minneapolis, MN, USA) compared with optimized medical management in patients with advanced chronic heart failure (NYHA class III) who were not eligible for treatment with cardiac resynchronization therapy, can be cost-effective from a statutory health insurance perspective in Germany over a lifetime horizon. The ICER was €27,951/QALY (95% CI €21,357–82,970).

Read more

25

Jun 2018

MTRC has developed reimbursement overviews for 14 EU countries. Overviews cover stakeholders, money flow, payment model, DRG system, innovation funding, coverage with evidence development, the role of health technology assessment, funding frameworks and reimbursement pathways. Reports are delivered in PowerPoint. Video explanations are available as well.

Read more

04

Jun 2018

Report includes analysis for the following procedures: radiofrequency ablation, endoscopic plication and suturing, injection of bulking agents and endoscopic augmentation of the lower esophageal sphincter using hydrogel implants. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

04

Jun 2018

Report includes analysis for the following procedures: surgical clipping, endovascular placement of a flow diversion device, endovascular coiling and stent-assisted coiling. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

01

Jun 2018

European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.

Read more

25

Apr 2018

In April 2018, Oleg Borisenko with support from the MTRC launched an international stipend and mentoring program. The objective of the program is to support medical students in developing countries with achieving maximum results in a medical profession. For the first round of the program (six months until Oct 2018), three students were selected. The program includes a stipend, bi-weekly meetings on different subjects (goal setting, evidence-based medicine, clinical epidemiology, medical experiment, marketing, publication standards and others) and a personal mentoring of Oleg Borisenko.

Read more

19

Apr 2018

The CEO of MTRC co-authored the article "Cost–utility analysis of bariatric surgery", published in the leading European surgical journal, British Journal of Surgery. Analysis indicated that currently used surgical methods in England were found to be cost saving over the lifetime of individuals treated in England.

Read more

17

Jan 2018

Article “Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium” published in the “Journal of Medical Economics” provides insights about economic outcomes of bariatric surgery in Belgium using Markov modeling. Over the 10-year horizon, bariatric surgery led to a cost increment of €3,788 and 1.4 additional QALY (€2,809/QALY) compared with optimal medical management. Over lifetime horizon, surgery led to 1.1 life years and 5.0 QALY gains and €9,332/patient average cost savings.

Read more

04

Dec 2017

CEO of the MTRC, Dr. Oleg Borisenko will attend the "MedTech Access Leaders Forum" 5-7 of December in Berlin. Please, write to info@mtrconsult.com if you would be interested to arrange a meeting to discuss your market access needs in Europe. 

Read more

23

Nov 2017

We have developed a one-day training in market access for IVD companies, covering essential areas of reimbursement, funding, health technology assessment, the role of clinical and economic evidence, stakeholder engagement. The seminar is based on the in-house expertise and extensive interview program with laboratory experts. During the course, both general aspects of market access and specific pathways for IVD tests in 12 European countries are reviewed. CEO Oleg Borisenko performs seminar on the client’s facility.

Read more

07

Nov 2017

The article "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" published in the Journal of Hepatology provides valuable insights into efficacy, safety and cost outcomes of the innovative method for managing refractory ascites.

Read more

31

Oct 2017

The article "Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: a Retrospective Cohort Study—2006–2012" published in Obesity Surgery reviews the UK experience with bariatric surgery.

Read more

20

Sep 2017

CEO of the MTRC, Dr. Oleg Borisenko will be present at the 2nd Annual Medical Devices Sales and Marketing Conference, 28-29 of September in Cologne, Germany. Please, contact us at info@mtrconsult.com if you would like to arrange a meeting to discuss your needs with reimbursement and market access in Europe.

Read more

05

Jun 2017

MTRC has developed a comprehensive introductory course in European market access. Course has duration between few hours and one day and takes place on your site. Topics include payment mechanisms, reimbursement pathways, role of HTA, economic argumentation and others. The cost is 5,000 euros irrespective of number of participants and duration of the course.

Read more